콜플랜트 바이오테크놀로지스 (CLGN) 주가

콜플랜트 바이오테크놀로지스(CLGN)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $4.53 (+8.89%), 시가총액 $0.01B, 52주 최저~최고 $0.29 ~ $4.54.

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue fillers; 3D-bioprinted regenerative breast implants; Collage, a combinant human Collagen type I solution; VergenixSTR, a soft tissue matrix for the treatment of tendinopathy; and VergenixFG, a wound care product for the treatment of deep surgical incisions and deep wounds. It also prov

핵심 지표

• 현재가: $4.53 (+8.89%)
• 시가총액: $0.01B
• 52주 최저~최고: $0.29 ~ $4.54
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NASDAQ

콜플랜트 바이오테크놀로지스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

콜플랜트 바이오테크놀로지스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 0.95
• 순이익률: 0.00%
• 영업이익률: -52.50%

자주 묻는 질문